Other researchers have induced heterozygous BAP1 mutations in mice in order to investigate the incidence of MM in humans carrying BAP1 germline mutations, even with no known history of exposure to asbestos, as was the case for four members of a European family (45). This evidence concerns the gene BAP1 and Miyoshi myopathy.